Anzemet and Breastfeeding
At this time, researchers do not know if it is safe for breastfeeding women to take Anzemet. Breastfeeding women should talk to their healthcare provider before taking the medication. Since no studies have been conducted on whether the drug passes through breast milk, women who are taking Anzemet and breastfeeding should watch for any side effects in their infants.
It is unknown if Anzemet® (dolasetron mesylate) passes through breast milk in breastfeeding women. Consequently, it is also not known if Anzemet is safe for women who are breastfeeding.
No studies have been conducted on whether Anzemet passes through breast milk in humans. Additionally, it is not known if Anzemet causes any problems in breastfed infants. If your healthcare provider recommends that you take Anzemet while breastfeeding, be sure to watch for any side effects in your infant.
You may be wondering why no studies have been conducted on whether Anzemet passes through breast milk. In many situations, such studies would be considered unethical. Such studies might put infants (who cannot themselves consent to these studies) at risk. In general, most information about breastfeeding and medications is obtained through cases outside of formal clinical studies.
You should talk with your healthcare provider about Anzemet and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Anzemet and breastfeeding in your particular situation.